Nifty

:

25285.35

Sensex

:

82500.82

103.55 (0.41%)
328.72 (0.40%)

Login

Nifty
Sensex

:
:

25285.35
82500.82

103.55 (0.41%)
328.72 (0.40%)

Zota Health Care Ltd.

Pharmaceuticals & Drugs - Global

Rating :

64/99

BSE: Not Listed | NSE: ZOTA

Watchlist

NSE BSE

1457.90

10-Oct-2025

Open
High
Low
Previous Close

1559
1562.3
1420.5
1544.00

Volume
Traded Value (lacs)
52 Week High
52 Week Low

155937
230229903.7
1577
535

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

4,481.55
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

4,483.53
0.07%
21.14

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

14.79
22.34
27.89

EBITDA CAGR (%)

10 Years
5 Years
3 Years

1.69
78.13
9.01

PAT CAGR (%)

10 Years
5 Years
3 Years

5.37
206.06
113.81

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-
10.77
12.58

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
230.14
322.70

Earnings Forecasts:

(Updated: 11-10-2025)

Description 2024 2025 2026 2027
Adj EPS -20.68
P/E Ratio -70.50
Revenue 292.97
EBITDA -5.73
Net Income -56.4
ROA -16.9
P/B Ratio 18.66
ROE -35.96
FCFF -100.77
FCFF Yield -2.24
Net Debt 135.98
BVPS 78.12

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 78.01 52.20 49.44% 77.93 47.35 64.58% 68.13 42.84 59.03% 59.01 41.15 43.40%
Expenses 70.86 49.26 43.85% 73.98 46.96 57.54% 66.82 40.71 64.14% 55.77 38.05 46.57%
EBITDA 7.15 2.95 142.37% 3.95 0.39 912.82% 1.31 2.13 -38.50% 3.24 3.10 4.52%
EBIDTM 9.16% 5.65% 5.07% 0.81% 1.92% 4.97% 5.50% 7.53%
Other Income 2.23 0.47 374.47% 1.49 0.69 115.94% 1.69 0.38 344.74% 0.97 0.63 53.97%
Interest 0.04 0.42 -90.48% 0.08 0.06 33.33% 0.04 0.00 0 0.52 0.25 108.00%
Depreciation 0.80 0.68 17.65% 0.94 0.86 9.30% 0.82 0.83 -1.20% 0.73 0.77 -5.19%
PBT 8.54 2.32 268.10% 4.42 0.16 2,662.50% 2.14 1.67 28.14% 2.96 2.71 9.23%
Tax 2.64 0.74 256.76% 1.82 -0.07 - 0.06 0.51 -88.24% 0.61 0.92 -33.70%
PAT 5.90 1.58 273.42% 2.60 0.22 1,081.82% 2.08 1.16 79.31% 2.35 1.79 31.28%
PATM 7.57% 3.03% 3.34% 0.47% 3.05% 2.70% 3.99% 4.34%
EPS 1.98 0.53 273.58% 0.87 0.07 1,142.86% 0.70 0.39 79.49% 0.79 0.60 31.67%

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 103.58 56.30 83.98% 97.28 49.64 95.97% 72.12 46.93 53.68% 67.28 45.27 48.62%
Expenses 99.63 57.56 73.09% 94.81 51.12 85.47% 78.19 43.60 79.33% 68.15 40.85 66.83%
EBITDA 3.96 -1.26 - 2.47 -1.48 - -6.07 3.33 - -0.87 4.43 -
EBIDTM 3.82% -2.24% 2.54% -2.99% -8.42% 7.10% -1.29% 9.78%
Other Income 0.88 0.02 4,300.00% 1.00 0.46 117.39% 0.51 0.15 240.00% 0.54 0.40 35.00%
Interest 3.24 2.90 11.72% 3.46 1.68 105.95% 1.57 1.14 37.72% 2.85 1.14 150.00%
Depreciation 14.68 8.02 83.04% 14.32 6.80 110.59% 11.35 5.08 123.43% 9.51 4.80 98.12%
PBT -13.08 -12.16 - -14.31 -9.51 - -18.48 -2.73 - -12.69 -1.11 -
Tax 0.69 0.56 23.21% -1.42 -2.59 - 0.46 0.21 119.05% -0.51 0.54 -
PAT -13.78 -12.72 - -12.89 -6.92 - -18.94 -2.94 - -12.18 -1.65 -
PATM -13.30% -22.60% -13.25% -13.94% -26.27% -6.26% -18.10% -3.65%
EPS -4.81 -4.80 - -4.50 -2.68 - -6.78 -1.14 - -4.42 -0.64 -

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 283.08 257.16 166.52 138.32 131.51 106.82 95.11 85.63 77.84 71.58 64.73 Net Sales Growth 54.23% 54.43% 20.39% 5.18% 23.11% 12.31% 11.07% 10.01% 8.75% 10.58% Cost Of Goods Sold 168.25 155.39 104.45 88.25 87.54 73.34 66.30 57.01 51.04 45.15 42.11 Gross Profit 114.83 101.77 62.07 50.07 43.97 33.47 28.81 28.62 26.81 26.43 22.62 GP Margin 40.57% 39.57% 37.27% 36.20% 33.43% 31.33% 30.29% 33.42% 34.44% 36.92% 34.95% Total Expenditure 267.43 245.86 160.30 130.98 116.52 106.19 90.58 77.88 67.02 61.54 55.17 Power & Fuel Cost - 1.20 1.10 4.04 0.90 0.76 0.68 0.61 0.44 0.33 0.37 % Of Sales - 0.47% 0.66% 2.92% 0.68% 0.71% 0.71% 0.71% 0.57% 0.46% 0.57% Employee Cost - 29.04 18.76 10.68 9.10 8.56 9.59 8.02 6.28 5.79 4.79 % Of Sales - 11.29% 11.27% 7.72% 6.92% 8.01% 10.08% 9.37% 8.07% 8.09% 7.40% Manufacturing Exp. - 4.73 2.72 1.70 2.35 1.96 1.79 1.83 2.02 2.24 1.90 % Of Sales - 1.84% 1.63% 1.23% 1.79% 1.83% 1.88% 2.14% 2.60% 3.13% 2.94% General & Admin Exp. - 13.17 8.44 4.87 7.55 6.78 6.07 5.54 3.47 3.00 2.46 % Of Sales - 5.12% 5.07% 3.52% 5.74% 6.35% 6.38% 6.47% 4.46% 4.19% 3.80% Selling & Distn. Exp. - 40.85 24.66 21.27 9.01 14.62 5.88 4.46 3.46 4.82 3.45 % Of Sales - 15.89% 14.81% 15.38% 6.85% 13.69% 6.18% 5.21% 4.45% 6.73% 5.33% Miscellaneous Exp. - 1.47 0.16 0.16 0.07 0.16 0.28 0.41 0.32 0.21 3.45 % Of Sales - 0.57% 0.10% 0.12% 0.05% 0.15% 0.29% 0.48% 0.41% 0.29% 0.14% EBITDA 15.65 11.30 6.22 7.34 14.99 0.63 4.53 7.75 10.82 10.04 9.56 EBITDA Margin 5.53% 4.39% 3.74% 5.31% 11.40% 0.59% 4.76% 9.05% 13.90% 14.03% 14.77% Other Income 6.38 4.76 2.05 3.23 2.00 1.30 1.52 1.54 1.59 0.06 0.08 Interest 0.68 1.06 0.36 0.06 0.07 0.11 0.07 0.04 0.12 0.68 0.68 Depreciation 3.29 3.17 3.01 2.42 2.73 3.17 2.10 1.39 0.94 1.05 1.23 PBT 18.06 11.84 4.91 8.09 14.19 -1.34 3.88 7.86 11.36 8.36 7.72 Tax 5.13 3.23 1.53 2.03 3.61 -0.15 1.12 2.31 4.07 2.82 2.61 Tax Rate 28.41% 27.28% 31.16% 23.52% 25.44% 48.39% 28.87% 29.39% 35.89% 33.73% 33.81% PAT 12.93 8.62 3.38 6.59 10.58 -0.16 2.76 5.55 7.27 5.54 5.11 PAT before Minority Interest 12.93 8.62 3.38 6.59 10.58 -0.16 2.76 5.55 7.27 5.54 5.11 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 4.57% 3.35% 2.03% 4.76% 8.05% -0.15% 2.90% 6.48% 9.34% 7.74% 7.89% PAT Growth 172.21% 155.03% -48.71% -37.71% - - -50.27% -23.66% 31.23% 8.41% EPS 4.34 2.89 1.13 2.21 3.55 -0.05 0.93 1.86 2.44 1.86 1.71

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Net Sales 340.26 292.66 180.43 139.91 131.17 106.77 95.11 85.63 Net Sales Growth 71.73% 62.20% 28.96% 6.66% 22.85% 12.26% 11.07% Cost Of Goods Sold 156.10 137.30 96.70 83.27 86.62 73.28 66.30 57.01 Gross Profit 184.16 155.36 83.72 56.64 44.55 33.48 28.81 28.62 GP Margin 54.12% 53.09% 46.40% 40.48% 33.96% 31.36% 30.29% 33.42% Total Expenditure 340.78 298.75 172.87 133.25 116.73 106.19 90.60 77.89 Power & Fuel Cost - 4.33 2.31 1.35 0.94 0.77 0.68 0.61 % Of Sales - 1.48% 1.28% 0.96% 0.72% 0.72% 0.71% 0.71% Employee Cost - 83.58 29.24 12.15 9.48 8.56 9.59 8.02 % Of Sales - 28.56% 16.21% 8.68% 7.23% 8.02% 10.08% 9.37% Manufacturing Exp. - 5.62 2.78 1.72 2.35 1.96 1.79 1.83 % Of Sales - 1.92% 1.54% 1.23% 1.79% 1.84% 1.88% 2.14% General & Admin Exp. - 20.92 11.68 8.21 7.81 6.83 6.24 5.54 % Of Sales - 7.15% 6.47% 5.87% 5.95% 6.40% 6.56% 6.47% Selling & Distn. Exp. - 44.72 30.01 26.38 9.47 14.62 5.83 4.46 % Of Sales - 15.28% 16.63% 18.85% 7.22% 13.69% 6.13% 5.21% Miscellaneous Exp. - 2.27 0.16 0.16 0.07 0.16 0.18 0.41 % Of Sales - 0.78% 0.09% 0.11% 0.05% 0.15% 0.19% 0.48% EBITDA -0.51 -6.09 7.56 6.66 14.44 0.58 4.51 7.74 EBITDA Margin -0.15% -2.08% 4.19% 4.76% 11.01% 0.54% 4.74% 9.04% Other Income 2.93 2.42 1.16 2.62 1.99 1.31 1.52 1.54 Interest 11.12 10.78 4.79 2.56 0.32 0.11 0.07 0.04 Depreciation 49.86 43.20 20.09 11.96 3.67 3.17 2.10 1.39 PBT -58.56 -57.64 -16.16 -5.23 12.43 -1.39 3.86 7.86 Tax -0.78 -0.91 -1.82 1.08 3.53 -0.16 1.12 2.31 Tax Rate 1.33% 1.58% 11.26% -23.03% 28.40% 44.44% 29.02% 29.39% PAT -57.79 -56.40 -14.35 -5.77 8.91 -0.21 2.74 5.55 PAT before Minority Interest -57.99 -56.74 -14.35 -5.77 8.91 -0.21 2.74 5.55 Minority Interest -0.20 0.34 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -16.98% -19.27% -7.95% -4.12% 6.79% -0.20% 2.88% 6.48% PAT Growth 0.00% - - - - - -50.63% EPS -19.39 -18.93 -4.82 -1.94 2.99 -0.07 0.92 1.86

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 317.37 121.78 94.46 91.37 66.37 68.85 68.93 69.78 26.98 21.44 Share Capital 28.64 25.85 25.16 25.16 24.56 24.56 17.54 17.54 14.36 14.36 Total Reserves 288.73 95.93 69.30 66.21 41.81 44.29 51.39 52.23 12.62 7.08 Non-Current Liabilities 1.64 1.15 0.85 0.96 0.95 1.05 0.87 0.65 3.03 2.73 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.46 2.23 Long Term Provisions 1.79 1.18 0.94 1.03 0.94 0.87 0.76 0.49 0.45 0.34 Current Liabilities 60.56 50.33 29.24 32.88 18.20 18.59 19.82 21.37 23.79 19.88 Trade Payables 46.23 30.84 24.82 18.32 15.59 14.99 16.17 16.47 18.36 14.60 Other Current Liabilities 7.60 1.31 0.95 10.00 1.67 1.64 0.52 0.31 0.36 0.40 Short Term Borrowings 0.20 14.68 0.00 0.00 0.00 0.00 0.00 0.00 1.64 0.00 Short Term Provisions 6.53 3.50 3.47 4.56 0.94 1.96 3.12 4.59 3.44 4.88 Total Liabilities 379.57 173.26 124.55 125.21 85.52 88.49 89.62 91.80 53.80 44.05 Net Block 12.25 11.94 11.45 12.56 13.99 15.41 9.78 9.56 6.72 7.23 Gross Block 39.43 35.95 32.45 31.14 29.84 28.09 20.36 18.76 14.98 14.45 Accumulated Depreciation 27.18 24.01 21.00 18.58 15.85 12.68 10.59 9.19 8.26 7.23 Non Current Assets 193.29 44.26 36.75 50.01 24.39 29.73 27.24 36.05 9.33 8.56 Capital Work in Progress 5.58 4.80 3.10 0.00 0.04 0.00 1.55 0.04 2.50 1.13 Non Current Investment 116.24 6.77 9.54 34.84 9.99 14.03 15.62 26.15 0.00 0.09 Long Term Loans & Adv. 59.22 20.75 12.67 2.61 0.37 0.29 0.29 0.31 0.11 0.11 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 186.28 128.99 87.80 75.21 61.13 58.76 62.37 55.74 44.48 35.50 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 59.56 40.06 35.83 27.98 28.13 25.34 32.51 24.28 23.91 16.33 Sundry Debtors 103.04 73.71 43.56 38.32 28.84 29.14 22.10 22.93 17.08 15.78 Cash & Bank 1.35 0.14 0.88 2.20 1.33 0.73 1.69 2.46 0.14 0.76 Other Current Assets 22.34 1.09 0.97 0.04 2.84 3.55 6.07 6.07 3.35 2.63 Short Term Loans & Adv. 21.06 13.99 6.56 6.67 2.20 3.27 3.54 5.63 3.08 2.60 Net Current Assets 125.72 78.67 58.56 42.33 42.94 40.17 42.56 34.37 20.69 15.61 Total Assets 379.57 173.25 124.55 125.22 85.52 88.49 89.61 91.79 53.81 44.06

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Shareholder's Funds 223.68 89.98 80.36 89.63 66.30 68.83 68.93 Share Capital 28.64 25.85 25.16 25.16 24.56 24.56 17.54 Total Reserves 195.05 64.13 55.20 64.47 41.74 44.27 51.38 Non-Current Liabilities 102.72 60.26 36.12 13.35 0.95 1.05 0.87 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 4.99 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 3.82 1.50 0.98 1.04 0.94 0.87 0.76 Current Liabilities 100.61 73.68 40.52 35.96 18.23 18.60 19.81 Trade Payables 42.40 33.61 26.46 18.70 15.60 14.99 16.17 Other Current Liabilities 41.53 19.06 10.32 12.63 1.67 1.64 0.52 Short Term Borrowings 0.61 14.68 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 16.08 6.34 3.74 4.63 0.96 1.96 3.13 Total Liabilities 430.48 223.92 157.00 138.94 85.48 88.48 89.61 Net Block 185.38 102.70 62.08 29.10 14.08 15.41 9.78 Gross Block 257.11 145.79 85.08 47.91 29.93 28.09 20.36 Accumulated Depreciation 71.72 43.09 23.00 18.81 15.85 12.68 10.59 Non Current Assets 246.33 112.31 72.82 62.03 24.27 29.61 27.23 Capital Work in Progress 6.48 4.80 3.10 0.00 0.04 0.00 1.55 Non Current Investment 54.35 4.70 7.53 32.84 9.89 13.92 15.61 Long Term Loans & Adv. 0.11 0.11 0.11 0.09 0.27 0.28 0.29 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 184.16 111.62 84.17 76.90 61.21 58.86 62.37 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 105.68 53.77 41.79 28.95 28.18 25.34 32.51 Sundry Debtors 40.50 27.24 27.83 36.37 28.77 29.14 22.10 Cash & Bank 3.62 1.00 1.12 2.30 1.35 0.83 1.69 Other Current Assets 34.36 7.77 2.76 0.94 2.91 3.55 6.07 Short Term Loans & Adv. 31.10 21.84 10.68 8.35 2.25 3.27 3.54 Net Current Assets 83.55 37.93 43.65 40.94 42.98 40.27 42.56 Total Assets 430.49 223.93 156.99 138.93 85.48 88.47 89.60

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity -22.21 -30.14 -10.29 13.66 -0.84 5.55 -3.24 -4.43 3.35 4.56 PBT 11.84 4.91 8.62 14.19 -0.32 3.88 7.86 11.34 8.36 7.72 Adjustment -0.09 1.54 0.51 1.46 1.45 1.06 0.01 -0.41 1.71 1.85 Changes in Working Capital -30.57 -35.08 -17.29 1.75 -1.91 1.71 -8.78 -11.32 -3.85 -2.32 Cash after chg. in Working capital -18.81 -28.63 -8.15 17.40 -0.78 6.65 -0.92 -0.39 6.22 7.25 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -3.40 -1.52 -2.14 -3.73 -0.06 -1.10 -2.32 -4.04 -2.87 -2.69 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -147.85 -8.67 12.76 -27.06 3.91 -3.54 8.83 -26.19 -1.81 -1.35 Net Fixed Assets -4.26 -5.20 -4.41 -1.26 -1.79 -6.18 -3.11 -1.32 -1.90 -1.34 Net Investments -109.47 2.77 25.30 -24.85 4.04 1.59 10.53 -26.15 0.09 -0.01 Others -34.12 -6.24 -8.13 -0.95 1.66 1.05 1.41 1.28 0.00 0.00 Cash from Financing Activity 171.27 38.08 -3.79 14.27 -2.47 -2.97 -6.35 32.94 -2.16 -2.62 Net Cash Inflow / Outflow 1.21 -0.73 -1.32 0.87 0.60 -0.97 -0.77 2.33 -0.62 0.59 Opening Cash & Equivalents 0.14 0.88 2.20 1.33 0.73 1.69 2.46 0.14 0.76 0.16 Closing Cash & Equivalent 1.35 0.14 0.88 2.20 1.33 0.73 1.69 2.46 0.14 0.76

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Cash From Operating Activity -49.96 -5.98 -2.01 13.33 -0.89 5.56 -3.25 PBT -57.64 -16.16 -4.69 12.43 -0.37 3.86 7.86 Adjustment 51.15 23.69 13.12 2.66 1.45 1.06 0.01 Changes in Working Capital -39.99 -11.98 -8.29 1.97 -1.91 1.73 -8.79 Cash after chg. in Working capital -46.48 -4.45 0.13 17.07 -0.83 6.65 -0.93 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -3.48 -1.53 -2.14 -3.73 -0.06 -1.10 -2.32 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -92.19 -12.90 14.70 -26.65 3.82 -3.54 8.83 Net Fixed Assets -4.26 -5.20 -4.41 -1.26 -1.79 -6.18 Net Investments -109.47 2.77 25.30 -24.85 4.04 1.59 Others 21.54 -10.47 -6.19 -0.54 1.57 1.05 Cash from Financing Activity 144.76 18.78 -13.88 14.27 -2.42 -2.87 -6.35 Net Cash Inflow / Outflow 2.61 -0.11 -1.18 0.95 0.51 -0.86 -0.77 Opening Cash & Equivalents 1.00 1.12 2.30 1.35 0.83 1.69 2.46 Closing Cash & Equivalent 3.62 1.00 1.12 2.30 1.35 0.83 1.69

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 110.83 47.11 37.54 36.32 27.02 28.03 28.06 28.41 13.42 10.66 ROA 3.12% 2.27% 5.28% 10.04% -0.19% 3.10% 6.12% 9.98% 11.32% 12.10% ROE 3.92% 3.13% 7.10% 13.41% -0.24% 4.01% 8.01% 15.02% 22.89% 25.70% ROCE 5.68% 4.57% 9.35% 18.09% -0.30% 5.73% 11.39% 22.73% 33.04% 35.60% Fixed Asset Turnover 6.83 4.87 4.35 4.31 3.69 3.93 4.38 4.62 4.86 4.51 Receivable days 125.38 128.48 108.00 93.18 99.04 98.30 95.96 93.80 83.78 77.44 Inventory Days 70.66 83.15 84.17 77.85 91.33 111.01 121.05 112.98 102.60 95.73 Payable days 90.51 97.26 89.20 70.68 76.08 85.76 73.03 99.18 89.74 90.17 Cash Conversion Cycle 105.53 114.37 102.96 100.35 114.29 123.55 143.97 107.60 96.63 83.00 Total Debt/Equity 0.00 0.12 0.00 0.00 0.00 0.00 0.00 0.00 0.15 0.10 Interest Cover 12.22 14.45 137.22 194.87 -1.88 57.15 214.57 94.67 13.25 12.30

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Book Value (Rs.) 78.12 34.81 31.94 35.62 26.99 28.02 28.06 ROA -17.34% -7.53% -3.90% 7.94% -0.24% 3.08% 6.19% ROE -36.18% -16.85% -6.79% 11.43% -0.31% 3.98% 8.05% ROCE -28.07% -12.30% -2.50% 16.36% -0.38% 5.71% 11.45% Fixed Asset Turnover 1.45 1.56 2.10 3.37 3.68 3.93 4.21 Receivable days 42.20 55.69 83.71 90.61 98.96 98.30 94.19 Inventory Days 99.32 96.62 92.24 79.46 91.46 111.01 138.59 Payable days 101.03 113.36 98.97 72.26 76.17 85.77 72.36 Cash Conversion Cycle 40.50 38.95 76.98 97.82 114.25 123.54 160.41 Total Debt/Equity 0.03 0.16 0.00 0.00 0.00 0.00 0.00 Interest Cover -4.35 -2.38 -0.83 39.77 -2.33 56.64 214.47

Top Investors:

asha mukul agrawal

mukul mahavir agrawal

valiant mauritius partners offshore limi

jainam broking limited

3p india equity fund 1

singularity equity fund i

Annual Reports:

News Update:

Zota Health Care - Quarterly Results
8th Aug 2025, 19:00 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback